Cost-Effectiveness Modelling of a 3-Month Tight Control Patient Management of Rheumatoid Arthritis with Certolizumab Pegol in France
Fagnani, F., Pham, T., Claudepierre, P., Berenbaum, F., De Chalus, T., Saadoun, C., Joubert, J.M., Fautrel, B.Volume:
16
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2013.08.1487
Date:
November, 2013
File:
PDF, 60 KB
english, 2013